NeuroMetrix Inc
Change company Symbol lookup
Select an option...
NURO NeuroMetrix Inc
OTTW Ottawa Savings Bancorp Inc
HMC Honda Motor Co Ltd
PAVMZ PAVmed Series Z Equity Warrants Exp 30 Apr 2024 *W EXP 04/30/2024
FFBW Ffbw Inc
CIB Bancolombia SA
TARA Protara Therapeutics Inc
SLAMU Slam Corp
SY So-Young International Inc
BHR Braemar Hotels & Resorts Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap Value
Company profile

NeuroMetrix, Inc. develops and commercializes health care products that utilize non-invasive neurostimulation. The Company is engaged in the designing, building and marketing of medical devices that stimulate nerves and analyze nerve response for diagnostic and therapeutic purposes. It has two principal product categories, which includes point-of-care neuropathy diagnostic tests and wearable neurostimulation devices. Its products include DPNCheck, Quell and ADVANCE System. DPNCheck is a quantitative nerve conduction test that is used to evaluate peripheral neuropathies, such as Diabetic peripheral neuropathy (DPN). Quell a wearable device for symptomatic relief and management of chronic pain. ADVANCE System is a platform for the performance of nerve conduction studies. DPNCheck customers include managed care organizations, endocrinologists, podiatrists and primary care physicians. ADVANCE System customers include occupational health, primary care, internal medicine and many others.

Closing Price
$3.64
Day's Change
-0.04 (-1.09%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.67
Day's Low
3.45
Volume
(Light)
Volume:
23,881

10-day average volume:
71,663
23,881

Gates on Musk's Tesla: 'There's a difference between electric cars being adopted and companies becoming infinitely valuable'

8:15 am ET May 7, 2022 (MarketWatch)
Print

By Rachel Koning Beals

Microsoft founder asked numerous times about Musk's 'anti-climate' charge, and the Tesla CEO's bid for Twitter

That's Microsoft (MSFT) founder Bill Gates, replying after being asked yet again about a public spat with Tesla founder and CEO Elon Musk, this time in an interview with the BBC.

Musk, who is also pursuing Twitter (TWTR), and Gates align in one significant way. Both donate heavily to climate-protection issues. Yet the two have a history of public disagreements on issues including the COVID-19 pandemic, electric trucks in particular, and cryptocurrencies.

In a recent tweet, Musk confirmed that he confronted Gates about shorting Tesla Inc.(TSLA). Gates had contacted his fellow billionaire to discuss philanthropy in climate change, but Musk asked if Gates still had a $500 million short position in Tesla.

Gates responded that he hadn't closed the position, to which Musk said he couldn't take Gates's philanthropy seriously if he was shorting the electric-car maker.

Read:Bill Gates says Elon Musk's approach to misinformation could make Twitter worse

Gates was also asked about Musk Wednesday, this time at The Wall Street Journal's CEO Council Summit. Gates fielded a question about the role of social media in spreading misinformation, and on the next beat, about Musk's $44 billion takeover offer for the platform and the risk of greater misinformation.

"He actually could make it worse," Gates said at the event.

"I have nothing but positive things to say about Elon. If he makes Twitter worse, fine, I'll speak out about that, but I wouldn't assume that's what's going to happen," Gates added.

Gates said at the summit that he sees no connection between efforts to slow global warming and an opinion on a particular stock.

Read:Can Bill Gates -- 'another rich guy with an opinion' -- move the needle on climate change?

"I don't think whether one's short or long Tesla is a statement about your seriousness about climate change," Gates said, commending Tesla for a role in mitigating man-made warming.

Tesla's stock is down nearly 10% in the year to date, but up about 42% from where it stood a year ago.

"There's no need for him to be nice to me," Gates said later of Musk on the BBC Today program.

-Rachel Koning Beals

	

(END) Dow Jones Newswires

May 07, 2022 08:15 ET (12:15 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.